MDS is a group of disorders in which the bone marrow does not work well and fails to make enough healthy blood cells. People diagnosed with MDS can have low numbers of red blood cells, white blood cells, or platelets, or a combination of any of these.
During this program, recorded on March 29, 2016, Dr. Doug Smith, an MDS expert from Johns Hopkins University, uses a number of real life case studies to help you understand MDS and its treatment. During this program he explains MDS, discusses possible causes and defines symptoms you might experience. He also covers treatment options for both lower and higher-risk MDS. This includes drug therapies approved specifically to treat MDS, such as chemotherapies, stem cell transplantation, and supportive care therapies like blood transfusions and growth factors. He ends with some practical tips for taking charge of your care. As with all our webinars, plenty of time will be provided at the end to answer your questions.
By the end of this program, you will:
- Understand the difference between low-risk and high risk MDS
- Understand the MDS classification and scoring systems and what they mean in regards to your diagnosis
- Understand your treatment options as well as the advances in MDS treatment, particularly bone marrow transplants in older MDS patients
- Understand the relationship between MDS and acute myeloid leukemia (AML)
- Understand what personalized medicine means in relationship to MDS
- Understand how to take an active role in your care
To download the transcript for this program:
- Click the presentation link down below
- Select Resources tab
- Download PDF of transcription